Development of Hyperthyroidism Following Primary Hypothyroidism: A Case Report  by Chung, Yueh-Hua et al.
Kaohsiung J Med Sci April 2004 • Vol 20 • No 4
Y.H. Chung, H.Y. Ou, and T.J. Wu
188
DEVELOPMENT OF HYPERTHYROIDISM FOLLOWING
PRIMARY HYPOTHYROIDISM: A CASE REPORT
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Development of hyperthyroidism following primary hypothyroidism is uncommon, and only a few
documented cases have been reported. Alterations in thyroid-stimulating hormone receptor antibodies
in serum are currently considered to play the main role in the pathophysiology, but the exact mechanism
is still unknown. Here, we report the case of a 60-year-old man with disturbed consciousness due to
hyponatremia. Thyroid function tests showed primary hypothyroidism with a high anti-microsomal
antibody titer (1:6,400). The patient experienced weight loss and exophthalmos 6 years later. Serum thyroid
hormone levels were increased and thyroxine treatment was discontinued, but the patient remained
thyrotoxic 2 months later. 131I thyroid uptake was 40.9% at 24 hours, and bilateral thyroid lobes were not
enlarged with diffuse radioactivity. Six months later, the patient was still thyrotoxic and therapy with
methimazole 10 mg/day was started. He is now taking methimazole and is euthyroid.
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Hypothyroidism following Graves’ hyperthyroidism spon-
taneously or after anti-thyroid drug treatment is well known,
and is believed to be due to destruction of the thyroid gland [1]
or the appearance of blocking thyroid-stimulating hormone
(TSH) receptor antibodies [2]. However, the development of
hyperthyroidism following primary hypothyroidism is un-
common and the mechanism of this phenomenon is unknown.
We present a patient who developed hyperthyroidism fol-
lowing primary hypothyroidism, and review similar cases in
the medical literature.
CASE PRESENTATION
In March 1992, a 60-year-old male presented to our institution
for consciousness disturbance. He had no history of serious
illnesses, thyroid diseases, surgery or drug consumption.
Hyponatremia (113 mmol/L) was noted, so thyroid function
was tested. A diagnosis of primary hypothyroidism was
made on the basis of low serum thyroxine (T4) (1.1 µg/dL)
and triiodothyronine (T3) (32.6 ng/dL), and high TSH
(153.429 µU/mL) and positive microsomal antibody
(1:6,400). He did not have exophthalmos and the thyroid
gland was not palpable. 131I thyroid uptake in April 1992
was 1.7% (4–12%) at 2 hours and 0.78% (15–40%) at 24
hours; both thyroid lobes were hardly visible on scintigra-
phy due to the very low uptake of radioiodine. After treat-
ment with T4, the clinical manifestation regressed and thy-
roid hormone levels became normal. The patient was treated
with T4 200 mg/day and regularly followed at the outpatient
clinic, where he had normal serum T4 (7.4–10.4 µg/dL) and
mildly elevated serum TSH (6.562–14.061 µU/mL).
In February 1998, the patient presented with weight
loss. Serum T4 concentration was 13.9 µg/dL, T3 was
240.7 ng/dL and TSH was 0.024 µU/mL. He had mild
exophthalmos without soft-tissue, extraocular-muscle or
corneal involvement. Goiter size did not increase. T4 therapy
was tapered and discontinued by September 1998. After
withdrawal of T4 therapy, 131I thyroid uptake in November
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1998 was 1.31% at 2 hours and 40.9% at 24 hours; scintigra-
phy showed that the bilateral thyroid lobes were not
enlarged with diffuse radioactivity.
Six months later, the patient was still thyrotoxic, with
elevated serum T4 and T3 concentrations, and therapy with
methimazole 10 mg/day was started. He became euthyroid
after the start of methimazole therapy. In May 2002, he re-
developed hypothyroidism, with low serum T4 (1.5 µg/dL)
and high TSH (178.43 µU/mL) concentrations, when the
methimazole dose was titrated from 20 to 30 mg/day. After
the methimazole dosage was decreased to 15 mg/day, he
became euthyroid and remained so until the time of wri-
ting. His clinical course, laboratory findings and changes in
thyroid-related antibodies are shown in the Figure and
Table.
DISCUSSION
The diagnosis of primary hypothyroidism in this patient
was well founded, as shown by hyponatremia with low
serum T4 and high serum TSH levels. The presence of a
high anti-microsomal antibody titer favors the possibility
of autoimmune thyroiditis. The possibility of subacute
thyroiditis, silent thyroiditis or drug-induced hypothy-
roidism was very low according to the patient’s clinical
course and laboratory findings. After the development of
hyperthyroidism, the possibility of transient thyrotoxicosis
due to destructive thyroiditis can be excluded, especially
when 131I thyroid uptake is not low.
Development of hyperthyroidism following primary
hypothyroidism is a rare phenomenon and only a few docu-
mented cases have been reported [3–7]. Primary hypothy-
roidism was traditionally thought to result from thyroid
destruction. Hence, it is amazing that a patient with primary
hypothyroidism subsequently develops hyperthyroidism.
It has been postulated that hypothyroidism previous to
hyperthyroidism may be due to TSH receptor blocking
antibodies, causing reversible hypothyroidism. The change
in the properties of TSH receptor antibodies from blocking
to stimulating results in development of hyperthyroidism
after primary hypothyroidism.
TSH receptor antibodies have been reported in about
10% of patients with atrophic autoimmune thyroiditis and
in about 20% of patients with goiterous autoimmune
thyroiditis [8,9]. Takasu et al reported the disappearance
of TSH receptor blocking antibodies and spontaneous reco-
very from hypothyroidism in 5% to 10% of patients with
chronic autoimmune thyroiditis [9]. If TSH receptor antibo-
dies change from blocking to stimulating in patients with
reversible primary hypothyroidism, these patients will
develop hyperthyroidism after primary hypothyroidism.
There are only 36 cases of hyperthyroidism following
primary hypothyroidism in the literature. Only three cases
documented alterations in TSH receptor antibodies from
blocking to stimulating [5–7]. As TSH receptor antibodies
Figure. Clinical course and
laboratory findings.
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were not detected during hypothyroidism in many of the
other cases, it is very difficult to explain the cause of re-
versible hypothyroidism. This phenomenon is currently
considered to be due to alterations in TSH receptor antibo-
dies in the serum of some patients, but the exact mechanism
remains unknown.
Our patient developed hypothyroidism during titration
of methimazole therapy in May 2002. It has been suggested
that patients such as these are very sensitive to anti-thyroid
drugs and easily develop hypothyroidism. The same phenom-
enon was noted among three cases reported by Takasu
et al [7].
In conclusion, our patient developed hyperthyroidism
6 years after being diagnosed with primary hypothyroid-
ism. Although it is a rare phenomenon, we should keep in
mind that primary hypothyroidism due to autoimmune
thyroiditis is not always a persistent state, and that hyper-
thyroidism may develop in some patients.
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